- Going back into the operating room for surgery to help a woman whose ovarian cancer has reappeared may not help her live longer - instead, it might shorten her life, according to an international study of 485 women.
The trial, known as GOG-0213, ended early when preliminary results showed that surgery was not helping. The volunteers had recurrent epithelial ovarian, primary peritoneal, or Fallopian-tube cancer. The women in the trial"ended up living three times longer than when we started the trial," said Coleman, who is executive director of cancer network research at M.D. Anderson.
"Patient-reported quality of life decreased significantly after surgery but did not differ significantly between the two groups after recovery," the study team writes. The two groups reached parity on the quality of life measure by the six-week mark.